Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 484,666 shares of the biopharmaceutical company’s stock ...
10d
Fintel on MSNBaird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform RecommendationFintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a ...
Baird initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ:CPRX) with an Outperform rating and set a price target ...
Baird analyst Joel Beatty last night initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target ...
The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...
The Palisades and Eaton fires in Los Angeles were fully contained Saturday, marking the end of a wave of historic blazes that scorched the region this month. Altadena was one of several ...
The deadly, wind-fueled Palisades and Eaton fires, which broke out 3½ weeks ago in Southern California, were declared fully contained Friday by the California Department of Forestry and Fire ...
Fire crews have reached a milestone in the devastating firestorm that rained embers and terror across Los Angeles County, achieving 100% containment of the Palisades ...
Lambert-Eaton Myasthenic Syndrome Market: The 7 major Lambert-Eaton myasthenic syndrome markets are expected to exhibit a CAGR of 5.15% during 2024-2034. Congenital Hyperinsulinism Market: The 7 major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results